282 Dual antigen targeting CAR T cells armored with a dominant-negative TGF-β Receptor II enhance antitumor potency by overcoming TGF-β immunosuppression in GBM by Zev Binder, Donald O’Rourke, Nannan Li, Jesse Rodriguez

1142 mRNA LNP vaccination with the tumor-specific antigen EGFRvIII bolsters CAR T cell activity in vivo by Tyler E Papp, Hamideh Parhiz, Jesse L Rodriguez, Logan Zhang, Kelly A Hicks, Zev Binder, Donald O’Rourke

2137 Percentage of viable tumor Versus radiation treatment effect in surgical specimens is not associated with outcomes in recurrent glioblastoma by Robert D. Schwab, Stephen Bagley, Zev Binder, Robert Lustig, Donald O’Rourke, Steven Brem, Arati S. Desai, MacLean Nasrallah

Get full text

Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune... by David B Weiner, Donald O’Rourke, Kevin Liaw, Pratik S Bhojnagarwala, Devivasha Bordoloi, Daniel H Park, Nicholas J Tursi, Shushu Zhao, Zev A Binder

Get full text

5 Severely immunodeficient NOG-EXL mice allow for humanization and development of a human glioblastoma-derived tumor microenvironment by Cecile Alanio, Zev Binder, Donald O’Rourke, Charles-Antoine Assenmacher, Lamia Lamrani, Anthony Secreto, Nicholas Skuli, Moriah Jacobson, Elinor Willis, Enrico Radaelli, Maclean Nasrallah